15 reports

It is also being studied for use against some leukemia, lymphomas, and other cancers, as well as some other diseases.

  • Interferon
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

It is being studied Page## Chapter IV PNEUMONIA TREATMENT DRUGS PRODUCTION AND DEMAND for use against some pneumonia, leukemia, lymphomas, and other cancers, as well as some other diseases.

  • Interferon
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.

IT IS ALSO BEING STUDIED FOR USE AGAINST SOME LEUKEMIA, LYMPHOMAS, AND OTHER CANCERS, AS WELL AS SOME OTHER DISEASES.

  • Interferon
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

The auto exports exceeded over ## million each year.

  • Interferon
  • China
  • Trade
  • Lijun Pharmaceutical Co., Ltd.
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd

It is being studied Page## Chapter IV PNEUMONIA TREATMENT DRUGS PRODUCTION AND DEMAND for use against some pneumonia, leukemia, lymphomas, and other cancers, as well as some other diseases.

  • Interferon
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.

## ## ## ## ## ## ## Shire Plc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Gilead Sciences Inc ## ## ## ## ## ## ## ## Galena Biopharma Inc ## ## ## ## ## ## ## ## F.

  • Clinical Trial
  • Interferon
  • Leukemia
  • World
  • Product Initiative

LYMPHOMA (DLBCL).

  • Antiviral
  • Hepatitis
  • Interferon
  • Therapy
  • Bristol-Myers Squibb Company

THE DRUG CANDIDATE IS IN PHASE II FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA (AS SECOND-LINE THERAPY), FOLLICULAR LYMPHOMA (AS SECONDLINE THERAPY) IN EU AND U. S.

  • Hepatitis
  • Interferon
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Bristol-Myers Squibb Company ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Bukwang Pharm Co Ltd ## ## ## ## ## ##

  • Hepatitis
  • Infectious Disease
  • Interferon
  • World
  • GlaxoSmithKline plc

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Interferon
  • Pharmaceutical
  • World
  • Product Initiative

R## is currently being administered to patients in Phase II clinical trials, one investigating B-cell lymphoma, one investigating T-cell lymphoma, another in immune thrombocytopenia purpura (ITP), and the fourth investigating certain solid tumors.

  • Interferon
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • BioLineRx Ltd.

The prominent features of this report are - ##.

  • Clinical Trial
  • Interferon
  • Neurological Disorder
  • Protein Therapy
  • Biogen Idec Inc.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## Conatus Pharmaceuticals Inc ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## Norgine BV ## ## ## ## ## ## ## Otsuka Holdings Co Ltd ## ## ## ## ## ## ## Ocera Therapeutics Inc ##

  • Clinical Trial
  • Digestive System Disorder
  • Interferon
  • Therapy
  • World

The prominent features of this report are - ##.

  • Brain Cancer
  • Interferon
  • Therapy
  • World
  • Product Initiative

## Preclinical ## Discovery ## NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H## 2016 Genital Warts (Condylomata Acuminata) - Therapeutics under Development by Companies NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H## 2016 Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELO

  • Interferon
  • Research And Development
  • United States
  • Company Operations
  • Helix BioPharma Corp.